Every 8-K that Nexentis Technologies Inc. (NXTS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow NXTS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full NXTS filings page.
Nexentis Technologies Inc. (NXTS) has been notified by Nasdaq that it is no longer in compliance with the minimum stockholders’ equity requirement for continued listing under Nasdaq Listing Rule 5550(b)(1), which requires at least $2,500,000 of stockholders’ equity. Nexentis reported $1,782,000 of stockholders’ equity as of June 30, 2026 in its Form 10‑Q.
The notice does not immediately affect trading of Nexentis common stock on The Nasdaq Capital Market. The company has 45 days, until October 15, 2026, to submit a plan to regain compliance. If Nasdaq accepts the plan, Nexentis may receive up to a 180‑day extension through February 27, 2027 to restore compliance. If a plan is not accepted or compliance is not regained, Nasdaq staff would issue a delisting determination, which Nexentis could appeal to a Nasdaq Hearings Panel, staying any delisting while the appeal is pending.
Nexentis Technologies Inc. changed its external auditor. On August 6, 2026, the board and audit committee dismissed Somekh Chaikin, a member firm of KPMG International (“KPMG Israel”), as the company’s independent registered public accounting firm and appointed Brightman Almagor Zohar & Co., a firm in the Deloitte Global Network (“Deloitte Israel”), to audit the consolidated financial statements for the year ended December 31, 2026.
KPMG Israel’s reports for the years ended December 31, 2025 and 2024 contained an explanatory paragraph stating that Nexentis had suffered recurring losses from operations and had a net capital deficiency that raise substantial doubt about its ability to continue as a going concern. The company states there were no disagreements or reportable events with KPMG Israel under Regulation S‑K Items 304(a)(1)(iv) and (v), and KPMG Israel provided a letter (Exhibit 16.1) agreeing with these statements.
Nexentis Technologies Inc. agreed to raise capital through a registered direct offering and concurrent private placement. The company will sell 410,998 shares of common stock at $7.056 per share, a premium to the Nasdaq Minimum Price, and issue 410,998 five-year warrants with the same exercise price.
The transactions are expected to generate approximately $2.9 million in gross proceeds, before expenses, and are scheduled to close on or about June 24, 2026, subject to customary conditions. Nexentis must file a resale registration statement for the warrant shares within 30 days of closing and have it declared effective within 60 days.
Nexentis Technologies Inc. entered into a securities purchase agreement with institutional investors for a registered direct offering and concurrent private placement. The company agreed to sell 311,876 shares of common stock and issue 311,876 warrants to buy up to 311,876 additional shares.
The warrants are exercisable immediately at $4.008 per share, have a five-year term, and may be exercised on a cashless basis if no effective registration statement is available. Aggregate gross proceeds from the combined offerings are about $1.25 million before expenses, with closing expected on or about June 15, 2026, subject to customary conditions.
Nexentis Technologies Inc. entered into an amended and restated facility agreement with L.I.A. Pure Capital Ltd., increasing its credit facility from EUR 6,000,000 to EUR 10,000,000. The facility continues to finance projects, including EUR 2,000,000 earmarked for one project in Germany and the remainder for other projects subject to lender pre-approval.
The amendment also updates warrant terms. The lender’s existing five-year warrant to purchase 1,850,000 shares of common stock at an exercise price of $1.00 per share now includes an enhanced anti-dilution adjustment, adding a “price maintenance” provision that can reduce the exercise price and/or increase warrant shares if future securities are issued below the then-current exercise price.
Nexentis Technologies Inc. held a special shareholder meeting where investors approved several key proposals affecting its capital structure. As of the record date March 10, 2026, there were 5,111,362 common shares outstanding, each entitled to one vote, and 3,129,968 shares were represented, equal to about 61.23% of voting power.
Shareholders approved a reverse stock split amendment allowing the board to choose a ratio between 1-for-2 and 1-for-500, with 2,855,535 votes for and 272,430 against. They also approved issuing securities in one or more non-public offerings with up to a 20% discount to the market price under Nasdaq Rule 5635(d), by a vote of 2,230,497 for and 112,345 against.
In addition, shareholders approved potential issuance of common shares upon exercise of warrants that may be issued under an amendment to the company’s facility agreement with L.I.A. Pure Capital Ltd., with 1,789,433 votes for and 98,561 against. A proposal to permit adjournment of the meeting if more time were needed for votes also passed, supported by 2,949,940 votes.
Nexentis Technologies Inc. is implementing a reverse stock split of its common stock at a one-for-seven ratio. On April 3, 2026, the company filed a Certificate of Amendment in Nevada to effect this change, which becomes effective on April 7 at 4:15 p.m. Eastern Daylight Time.
At the market open on April 8, 2026, the common stock will begin trading on the Nasdaq Capital Market on a post-split basis under the symbol “NXTS” with a new CUSIP. Every seven issued and outstanding shares of common stock will automatically combine into one share, with no change to the $0.0001 par value and fractional shares rounded up to the next whole share.
The reverse split will reduce the number of shares outstanding from 5,111,362 to approximately 730,309, with proportional adjustments to equity awards, convertible notes, and warrants. Authorized capital will remain at 495,000,000 common shares and 5,000,000 preferred shares, and each stockholder’s ownership percentage will stay essentially the same aside from de minimis rounding effects.
Nexentis Technologies Inc. has completed a strategic share exchange involving its majority-owned subsidiary Save Foods Ltd. and Voice Assist, Inc. On March 15, 2026, Nexentis transferred all of its Save Foods ordinary shares, representing approximately 98% of Save Foods’ issued and outstanding share capital, to Voice Assist.
In return, Nexentis received shares of Voice Assist common stock representing 19.99% of Voice Assist on a fully diluted basis, calculated immediately after closing. Nexentis also maintains a previously signed Services Agreement under which it provides advisory and related services to Voice Assist in exchange for deferred cash from future financings capped at $1,000,000, royalty consideration on defined “New Future Projects,” and a share of any “Ecolab Gross Proceeds.” The Services Agreement runs through calendar year 2026 with extension rights until all consideration is fully received.